[{"address1": "1359 Broadway", "address2": "Suite 1710", "city": "New York", "state": "NY", "zip": "10018", "country": "United States", "phone": "212 433 3791", "website": "https://zentalis.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.", "fullTimeEmployees": 124, "companyOfficers": [{"maxAge": 1, "name": "Ms. Andrea  Paul J.D.", "age": 43, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 682466, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Julie M. Eastland M.B.A.", "age": 60, "title": "CEO, President & Director", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vincent  Vultaggio", "age": 41, "title": "VP of Finance & Interim Principal Accounting Officer", "yearBorn": 1983, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark  Lackner Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Wendy  Chang", "title": "Chief People Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly  Freeman", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ingmar  Bruns M.D., Ph.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Haibo  Wang", "title": "Chief Business Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.43, "open": 2.48, "dayLow": 2.39, "dayHigh": 2.575, "regularMarketPreviousClose": 2.43, "regularMarketOpen": 2.48, "regularMarketDayLow": 2.39, "regularMarketDayHigh": 2.575, "beta": 1.813, "forwardPE": -0.98842764, "volume": 838592, "regularMarketVolume": 838592, "averageVolume": 1878901, "averageVolume10days": 2268070, "averageDailyVolume10Day": 2268070, "bid": 1.85, "ask": 3.09, "bidSize": 200, "askSize": 200, "marketCap": 173174928, "fiftyTwoWeekLow": 1.61, "fiftyTwoWeekHigh": 18.07, "priceToSalesTrailing12Months": 4.269599, "fiftyDayAverage": 2.722, "twoHundredDayAverage": 4.70815, "currency": "USD", "enterpriseValue": -174811072, "floatShares": 44467472, "sharesOutstanding": 71265400, "sharesShort": 4848542, "sharesShortPriorMonth": 4543953, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.068, "heldPercentInsiders": 0.14274, "heldPercentInstitutions": 0.9485, "shortRatio": 1.67, "shortPercentOfFloat": 0.137, "impliedSharesOutstanding": 80173600, "bookValue": 4.98, "priceToBook": 0.48795182, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -179284000, "trailingEps": -2.5, "forwardEps": -3.57, "enterpriseToRevenue": -4.31, "enterpriseToEbitda": 0.841, "52WeekChange": -0.82416785, "SandP52WeekChange": 0.22903383, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ZNTL", "underlyingSymbol": "ZNTL", "shortName": "Zentalis Pharmaceuticals, Inc.", "longName": "Zentalis Pharmaceuticals, Inc.", "firstTradeDateEpochUtc": 1585920600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "39a4bee6-8ddb-3930-b936-d5bcf9eb8cf7", "messageBoardId": "finmb_647536411", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.43, "targetHighPrice": 10.0, "targetLowPrice": 2.2, "targetMeanPrice": 6.27, "targetMedianPrice": 6.0, "recommendationMean": 2.18182, "recommendationKey": "buy", "numberOfAnalystOpinions": 10, "totalCash": 391252000, "totalCashPerShare": 5.49, "ebitda": -207958000, "totalDebt": 43266000, "quickRatio": 7.13, "currentRatio": 7.294, "totalRevenue": 40560000, "debtToEquity": 12.211, "revenuePerShare": 0.572, "returnOnAssets": -0.2524, "returnOnEquity": -0.42891, "grossProfits": 40560000, "freeCashflow": -81906872, "operatingCashflow": -171756992, "grossMargins": 1.0, "operatingMargins": -5.1594396, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]